The majority of published studies evaluate the role of pRNFL and GCIPL thickness measurements in the differential diagnosis of MS and other inflammatory CNS conditions, e.g., NMOSD, MOG antibody-associated disease, SLE, neurosarcoidosis, and Behcet’s disease [13,14,15,16,17,51]. Here, MOG is linked to myeloid sarcoma.